Pharosyn
Provides AI software designed to help pharmaceutical companies speed up commercial decision-making for teams evaluating market and business actions.
Overview
Pharosyn builds AI software for pharmaceutical commercial teams, with a stated focus on speeding up decisions across pharma business workflows. The company targets drugmakers and life-sciences organizations that need faster support for commercial planning, analysis, and execution. Its differentiation is its vertical focus on pharma’s commercial decision workflows rather than general enterprise analytics. The London-based company raised $3 million in an undisclosed round announced in September 2026.
Funding History
Exclusive: London’s Pharosyn raises $3M to speed up pharma’s commercial decisions
Frequently Asked Questions
- How much funding does AI Funding track for Pharosyn?
- AI Funding tracks $3M for Pharosyn across 1 funding round in this database.
- What does Pharosyn do?
- Pharosyn builds AI software for pharmaceutical commercial teams, with a stated focus on speeding up decisions across pharma business workflows. The company targets drugmakers and life-sciences organizations that need faster support for commercial planning, analysis, and execution. Its differentiation is its vertical focus on pharma’s commercial decision workflows rather than general enterprise analytics. The London-based company raised $3 million in an undisclosed round announced in September 2026.
- Where is Pharosyn headquartered?
- Pharosyn is headquartered in London, UK.
Related Insights
A data-driven analysis of AI funding across all 17 sectors — from Foundation Models to AI Healthcare — with sector totals, deal counts, top companies, and investment trends for 2026.
A comprehensive, data-driven analysis of AI venture funding in Q1 2026. $25.9 billion raised across 94 deals, with 14 mega-rounds capturing 79.8% of total capital. Europe breaks out with $6.65B, and billion-dollar seed rounds arrive for the first time.
A deep comparison of Science Corp.'s neurotech-driven brain-computer interfaces and Nscale's AI cloud infrastructure, examining how $230M and $2B in recent funding fuel fundamentally different visions of artificial intelligence.